Welcome to LookChem.com Sign In|Join Free

CAS

  • or
H-D-GLU(OME)-OME HCL, also known as D-Glutamic Acid 1,5-Dimethyl Ester Hydrochloride, is a diester analogue of D-Glutamic Acid, a non-essential amino acid. It is characterized by its crystalline chemical properties and is used in the synthesis of more complex pharmaceutical compounds.

27025-25-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 27025-25-8 Structure
  • Basic information

    1. Product Name: H-D-GLU(OME)-OME HCL
    2. Synonyms: Dimethyl D-Glutamate Hydrochloride;H-D-Glu(OMe)-OMeCl;H-D-GLU(OME)-OME HC;D-Glutamic Acid Dimethyl Ester Hydrochloride H-D-Glu(OMe)-OMe.HCl;D-Glu(OMe)-OMe.HCl;(R)-DiMethyl 2-aMinopentanedioate hydrochloride;D-Glu.2OMe.HCl;D-GlutaMic Acid 1,5-DiMethyl Ester Hydrochloride
    3. CAS NO:27025-25-8
    4. Molecular Formula: C7H14NO4*Cl
    5. Molecular Weight: 211.64
    6. EINECS: 1533716-785-6
    7. Product Categories: Amino Acid Methyl Esters;Amino Acids (C-Protected);Biochemistry;Amino ester;Amino Acid Derivatives;Amino Acids
    8. Mol File: 27025-25-8.mol
  • Chemical Properties

    1. Melting Point: 143 °C
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: Crystalline subtance
    5. Density: N/A
    6. Refractive Index: -26.0 ° (C=2, MeOH)
    7. Storage Temp.: 2-8°C
    8. Solubility: DMSO, Methanol, Water
    9. Sensitive: Hygroscopic
    10. CAS DataBase Reference: H-D-GLU(OME)-OME HCL(CAS DataBase Reference)
    11. NIST Chemistry Reference: H-D-GLU(OME)-OME HCL(27025-25-8)
    12. EPA Substance Registry System: H-D-GLU(OME)-OME HCL(27025-25-8)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 27025-25-8(Hazardous Substances Data)

27025-25-8 Usage

Uses

Used in Pharmaceutical Industry:
H-D-GLU(OME)-OME HCL is used as a building block for the synthesis of complex pharmaceutical compounds due to its diester analogue nature and non-essential amino acid properties.
Used in Research and Development:
H-D-GLU(OME)-OME HCL is used as a research compound for studying the properties and potential applications of D-Glutamic Acid and its derivatives in various scientific and medical fields.
Used in Drug Synthesis:
H-D-GLU(OME)-OME HCL is used as a key intermediate in the synthesis of pharmaceutical drugs, contributing to the development of new medications with potential therapeutic benefits.

Check Digit Verification of cas no

The CAS Registry Mumber 27025-25-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,7,0,2 and 5 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 27025-25:
(7*2)+(6*7)+(5*0)+(4*2)+(3*5)+(2*2)+(1*5)=88
88 % 10 = 8
So 27025-25-8 is a valid CAS Registry Number.
InChI:InChI=1/C7H13NO4.ClH/c1-11-6(9)4-3-5(8)7(10)12-2;/h5H,3-4,8H2,1-2H3;1H/t5-;/m1./s1

27025-25-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (D3560)  Dimethyl D-Glutamate Hydrochloride  >98.0%(N)(T)

  • 27025-25-8

  • 5g

  • 470.00CNY

  • Detail
  • TCI America

  • (D3560)  Dimethyl D-Glutamate Hydrochloride  >98.0%(N)(T)

  • 27025-25-8

  • 25g

  • 1,880.00CNY

  • Detail
  • Alfa Aesar

  • (H62132)  D-Glutamic acid dimethyl ester hydrochloride, 98%   

  • 27025-25-8

  • 1g

  • 176.0CNY

  • Detail
  • Alfa Aesar

  • (H62132)  D-Glutamic acid dimethyl ester hydrochloride, 98%   

  • 27025-25-8

  • 5g

  • 754.0CNY

  • Detail
  • Alfa Aesar

  • (H62132)  D-Glutamic acid dimethyl ester hydrochloride, 98%   

  • 27025-25-8

  • 25g

  • 3631.0CNY

  • Detail

27025-25-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name dimethyl (2R)-2-aminopentanedioate,hydrochloride

1.2 Other means of identification

Product number -
Other names H-D-Glu(Ome)-Ome HCl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:27025-25-8 SDS

27025-25-8Relevant articles and documents

Photochemical Deracemization at sp3-Hybridized Carbon Centers via a Reversible Hydrogen Atom Transfer

Bach, Thorsten,Breitenlechner, Stefan,Gro?kopf, Johannes,Plaza, Manuel,Seitz, Antonia,Storch, Golo

supporting information, p. 21241 - 21245 (2021/12/27)

A photochemical deracemization of 5-substituted 3-phenylimidazolidine-2,4-diones (hydantoins) is reported (27 examples, 69%-quant., 80–99% ee). The reaction is catalyzed by a chiral diarylketone which displays a two-point hydrogen bonding site. Mechanistic evidence (DFT calculations, radical clock experiments, H/D labeling) suggests the reaction to occur by selective hydrogen atom transfer (HAT). Upon hydrogen binding, one substrate enantiomer displays the hydrogen atom at the stereogenic center to the photoexcited catalyst allowing for a HAT from the substrate and eventually for its conversion into the product enantiomer. The product enantiomer is not processed by the catalyst and is thus enriched in the photostationary state.

Amino acid conjugates of 2-mercaptobenzimidazole provide better anti-inflammatory pharmacology and improved toxicity profile

Khan, Muhammad T.,Nadeem, Humaira,Khan, Arif-ullah,Abbas, Muzaffar,Arif, Muazzam,Malik, Nadia Shamshad,Malik, Zulkifal,Javed, Ibrahim

, p. 1057 - 1072 (2020/08/13)

Benzimidazole is an important pharmacophore for clinically active drugs against inflammation and treatment of pain, however, it is associated with gastrointestinal side effects. Here we synthesized benzimidazole based agents with significant analgesic/anti-inflammatory potential but with less gastrointestinal adverse effects. In this study, we synthesized novel, orally bioavailable 2-mercaptobenzimidazole amino acid conjugates (4a–4o) and screened them for analgesic, anti-inflammatory and gastro-protective effects. The synthesized 2-mercaptbenzimidazole derivatives were characterized for their structure using FTIR, 1H NMR and 13C NMR spectroscopic techniques. The 2-mercaptobenzimidazole amino acid conjugates have found to possess potent analgesic, anti-inflammatory and gastroprotective activities, particularly with compound 4j and 4k. Most of the compounds exhibited remarkable anti-ulcer and antisecretory effects. Molecular docking studies were carried out to study the binding affinities and interactions of the synthesized compounds with target proteins COX-2 (PDB ID: 3LN1) and H+/K+-ATPase (PDB ID: 5Y0B). Our results support the clinical promise of these newly synthesized 2-mercaptobezimidazol conjugates as a component of therapeutic strategies for inflammation and analgesia, for which the gastric side effects are always a major limitation.

Synthesis of ortho-carboranyl derivatives of (S)-asparagine and (S)-glutamine

Gruzdev,Levit,Olshevskaya,Krasnov

, p. 769 - 776 (2017/07/07)

(S)-Asparagine and (S)-glutamine ortho-carboranyl derivatives with free amino and carboxy groups in the α-position were synthesized. By an example of Nγ-(1,2-dicarba-closo-dodecarboran-3-yl)-(S)-glutamine it was demonstrated that the developed synthetic approach carboranyl derivatives of amino acids allowed the preparation of optically pure isomers.

Synthesis of modified peptidoglycan precursor analogues for the inhibition of glycosyltransferase

Dumbre, Shrinivas,Derouaux, Adeline,Lescrinier, Eveline,Piette, Andre,Joris, Bernard,Terrak, Mohammed,Herdewijn, Piet

supporting information; experimental part, p. 9343 - 9351 (2012/07/14)

The peptidoglycan glycosyltransferases (GTs) are essential enzymes that catalyze the polymerization of glycan chains of the bacterial cell wall from lipid II and thus constitute a validated antibacterial target. Their enzymatic cavity is composed of a donor site for the growing glycan chain (where the inhibitor moenomycin binds) and an acceptor site for lipid II substrate. In order to find lead inhibitors able to fill this large active site, we have synthesized a series of substrate analogues of lipid I and lipid II with variations in the lipid, the pyrophosphate, and the peptide moieties and evaluated their biological effect on the GT activity of E. coli PBP1b and their antibacterial potential. We found several compounds able to inhibit the GT activity in vitro and cause growth defect in Bacillus subtilis. The more active was C16-phosphoglycerate-MurNAc-(l-Ala-d-Glu)-GlcNAc, which also showed antibacterial activity. These molecules are promising leads for the design of new antibacterial GT inhibitors.

Relationships between the structure of 6-allyl-6,8-diazabicyclo[3.2.2]nonane derivatives and their σ receptor affinity and cytotoxic activity

Holl, Ralph,Schepmann, Dirk,Gruenert, Renate,Bednarski, Patrick J.,Wuensch, Bernhard

body text, p. 777 - 793 (2009/08/07)

A series of bridged piperazine derivatives was prepared and the affinity toward σ1 and σ2 receptors by means of radioligand binding assays as well as the inhibition of the growth of six human tumor cell lines was investigated. All possible stereoisomers of the 2-hydroxy, 2-methoxy, 2,2-dimethoxy, 2-oxo, and 2-unsubstituted 6,8-diazabicyclo[3.2.2]nonanes were prepared in a chiral pool synthesis starting with (S)- and (R)-glutamate. A Dieckmann analogous cyclization was the key step in the synthesis of the bicyclic framework. The configuration in position 2 was established by a diastereoselective LiBH4 reduction and subsequent Mitsunobu inversion. Structure-affinity relationships demonstrate that substituents in position 2 decrease σ1 receptor affinity which might be due to unfavorable interactions with the σ1 receptor protein. Without a substituent in position 2 high σ1 affinity was obtained (23a ((+)-(1S,5S)-6-allyl-8-(4-methoxybenzyl)-6,8-diazabicyclo[3.2.2]nonane): Ki = 11 nM). Experiments with six human tumor cell lines showed a weak but selective growth inhibition of the human small cell lung cancer cell line A-427 by the methyl ethers ent-16b (IC50 = 18.9 μM), 21a (IC50 = 16.4 μM), ent-21a (IC50 = 20.4 μM), and 21b (IC50 = 27.1 μM) and the unsubstituted compounds 23a and 23b (42% inhibition at 20 μM).

Synthesis and pharmacological evaluation of bicyclic SNC80 analogues with separated benzhydryl moiety

Jung, Bettina,Englberger, Werner,Froehlich, Roland,Schepmann, Dirk,Lehmkuhl, Kirstin,Wuensch, Bernhard

, p. 2870 - 2885 (2008/09/19)

Directed by molecular modeling studies the pharmacophoric benzhydryl moiety of the δ opioid receptor agonist SNC80 was separated and the two phenyl residues were attached to different positions of the conformationally constrained 6,8-diazabicyclo[3.2.2]nonane framework in order to find novel δ agonists. The crucial reaction step in the chiral pool synthesis was the establishment of the three carbon bridge by a Dieckmann analogous cyclization of the allyl and propyl derivatives 6 and 7 to yield the mixed methyl silyl acetals 8 and 9, respectively. Stereoselective Grignard reaction, dehydration, and introduction of the pharmacophoric (N,N-diethylcarbamoylbenzyl) residue led to the designed δ receptor agonists 3, ent-3, and 20 with a double bond in the bicyclic framework. Hydrogenation of the allyl derivative 14 was performed with ammonium formate and Pd/C to yield the saturated ligands 24a and 24b. Removal of the allyl substituent with RhCl3, hydrogenation of the ring system, and re-attachment of the allyl moiety provided the allyl derivatives 4a and 4b. In receptor binding studies with the radioligand [3H]-deltorphine II only ent-3 showed considerable δ receptor affinity (Ki = 740 nM). Since ent-3 also interacts with μ receptors (Ki = 250 nM) it belongs to the very interesting compound class of mixed δ/μ ligands.

Synthesis of bicyclic σ receptor ligands with cytotoxic activity

Geiger, Christian,Zelenka, Christel,Weigl, Manuela,Fr?hlich, Roland,Wibbeling, Birgit,Lehmkuhl, Kirstin,Schepmann, Dirk,Grünert, Renate,Bednarski, Patrick J.,Wünsch, Bernhard

, p. 6144 - 6153 (2008/09/16)

All possible stereoisomeric alcohols (6-benzyl-8-(4-methoxybenzyl)-6,8- diazabicyclo[3.2.2]nonan-2-ol) and methyl ethers (6-benzyl-2-methoxy-8-(4- methoxybenzyl)-6,8-diazabicyclo[3.2.2]nonane) are prepared from (R)- and (S)-glutamate. A Dieckmann analogous cyclization, which makes use of trapping the primary cyclization product with Me3SiCl, generates the bicyclic framework. Stereoselective LiBH4 reduction and Mitsunobu inversion establish the configuration in position 2. Enantiomeric alcohols 15 (1S,2S,5R) and ent-15 (1R,2R,5S) as well as diastereomeric methyl ethers ent-17 (1R,2R,5S) and ent-22 (1R,2S,5S) display high σ1 receptor affinity. Cell growth inhibition of the stereoisomeric alcohols and methyl ethers against five human tumor cell lines is investigated. In particular, at a concentration of 20 μthe four methyl ethers stop completely the cell growth of the small cell lung cancer cell line A-427, indicating a specific target in this cell line. The IC50-values of methyl ethers ent-17 and ent-22 are in the range of the antitumor drugs cisplatin and oxaliplatin. Binding assays show that the investigated tumor cell lines express considerable amounts of σ1 and σ2 receptors.

Engineering of Highly Luminescent Lanthanide Tags Suitable for Protein Labeling aad Time-Resolved Luminescence Imaging

Weibel, Nicolas,Charbonniere, Loic J.,Guardigli, Massimo,Roda, Aldo,Ziessel, Raymond

, p. 4888 - 4896 (2007/10/03)

The synthesis of a new ligand LH4 based on a glutamic acid skeleton bis-functionalized on its nitrogen atom by 6-methylene-6′ -carboxy-2,2′-bipyridine chromophoric units is described. UV-vis spectrophotometric titrations revealed the formation of 1:1 M:L complexes with lanthanide(III) cations, and complexation of LH4 with equimolar amounts of hydrated LnCl3 salts (Ln = Eu, Gd, and Tb) gave water-soluble and stable complexes of the general formula [LnL(H 2O)]Na, which were characterized by elemental analysis, IR, UV-vis absorption spectroscopy, 1H NMR (Ln = Eu), and mass spectrometry. The conditional stability constant for formation of the [EuL(H2O)]Na complex was determined by competitive complexation experiments to be log K= 16. 5 ± 0.6 in 0.01 M TRIS/HCl buffer (pH = 7.0). In water solution, the [EuL(H2O)]Na and [TbL(H2O)]Na complexes were highly luminescent with quantum yields of 8% and 31%, respectively, despite the presence of ca. one water molecule in the first coordination sphere of the metal ions. Activation of the appended carboxylate function of the glutamate moiety in the form of an N-hydroxysuccinimidyl ester allows for the covalent linking of the complexes to primary amino groups of biological compounds. Bovine serum albumin (BSA) was labeled with both Eu or Tb complexes, and the Ln-BSA conjugates were characterized by UV-vis absorption and emission spectroscopy and MALDI-TOF mass spectrometry. Labeling ratios (number of complex molecules per BSA) of ca. 8:1 and 7:1 were established for Eu-BSA and Tb-BSA, respectively. The suitability of the tagged compound for use in bioanalytical time-resolved luminescence microscopy was established by comparison with fluorescein-labeled probes.

New 2-(2'-phenyl-9'-benzyl-8'-azapurin-6'-ylamino)-carboxylic acid methylesters as ligands for A1 adenosine receptors.

Biagi,Giorgi,Pacchini,Livi,Scartoni

, p. 929 - 931 (2007/10/03)

Synthesis of a series of new 2-phenyl-9-benzyl-8-azaadenines bearing on N6 an alkyl or aralkyl chain having a carbonyloxymethyl group on the carbon bound to N6 were reported. The ester group could assure to the molecule a better water-solubility than the 8-azaadenines 2, 6 and 9 substituted with lipophilic groups synthesised in the past. Compounds synthesised demonstrated only little capability of binding A1 adenosine receptors.

Antiviral and tumor cell antiproliferative SAR studies on tetracyclic eudistomins-II

Van Maarseveen, Jan H.,Scheeren, Hans W.,De Clercq, Erik,Balzarini, Jan,Kruse, Chris G.

, p. 955 - 970 (2007/10/03)

In a search for the minimum pharmacophore of the naturally occurring tetracyclic eudistomins, five structural analogues (4-8) were evaluated for their in vitro antiviral and tumor cell antiproliferative activities. For the synthesis of these derivatives both intra- and intermolecular Pictet-Spengler reactions have been used. Opening of the P-carboline annulated 7-membered D-ring in 6 and 7 resulted in a complete loss of activity. On the other hand, replacement of either the oxygen atom or the sulfur atom in the 7-membered ring by a methylene group in 5 and 8, respectively, is allowed. These results combined with previous SAR data underline the crucial importance of the D-ring in eudistomins as a scaffold for the correct positioning of both basic nitrogen atoms. Also bioisosteric replacement of the bicyclic indole system with a dimethoxyphenyl group, to give the isoquinoline skeleton, is allowed. The tricyclic isoquinoline derivative 4 is, so far, the most promising antiviral analogue; it combines a high potency (MIG at 100 ng/ mL (340 nM)) with high MCC/MIC ratios (ranging from 1000 to 5000 against HSV-1, HSV-2, vaccinia virus, and vesicular stomatitis virus).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 27025-25-8